Elekta announced on Wednesday that Brainlab will be the exclusive distributor for its stereotactic neurosurgery products in the U.S.
The Munich-based company is already the distributor of these products in select European markets.
The agreement includes the Leksell Vantage Stereotactic System, which is Elekta's next-generation system for target localization and coordinate referencing for neurosurgical procedures.
It scored CE mark in March and has already been adopted by neurosurgeons in Europe. The system also recently received FDA clearance and is commercially available in the U.S.
In September 2016, Elekta and Brainlab started working together on integrating the Leksell Vantage and Brainlab's Elements Stereotaxy treatment planning and verification software. The combined use of both technologies is intended to make stereotactic neurosurgical procedures safer.
Elekta specifically chose Brainlab as the distributor of these products in the U.S. due to the company's large and specialized sales and service team.
The company, which was founded in 1989, has about 1,300 employees and operates 18 offices across Europe, Asia, Australia and North and South America.
It started as a software company with solutions ranging from patient positioning for radiosurgery to software-guided surgical navigation, and it has evolved to develop hardware systems.
"By partnering with Elekta, we are increasing our reach and providing clinicians with advanced and innovative technology on the stereotactic neurosurgery market," Paolo Jelmoni, VP of functional and stereotactic neurosurgery at Brainlab, said in a statement.